| Page | ||||
|---|---|---|---|---|
| Trustees' Annual Report (Incorporating the |
Director's Report) | |||
| independent Examiner's Report |
to the Trustees | |||
| Statement ofFinancial Activities | (Including | Income and Expenditure | Account) | |
| Statement ofFinancial Position |
||||
| Notes to the Financial Statements | 10 | |||
| The Following Pages Do Not |
Form Part | ofthe Financial Statements | ||
| Detailed Statement ofFinancial |
Activities | 18 |
| Refe e | e | and Administrative | and Administrative | and Administrative | and Administrative | Det | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Registered | charity name | Citizens Advice Cumbria | ||||||||
| Charity registration | number | 1079229 "' i. P |
||||||||
| Company | registration | number | 03865647 | |||||||
| Principal | oNce and | registered | C/o Citizens Advice Carlisle and Eden | Office | ||||||
| oNce | 2 Sandgate | |||||||||
| Penrith | ||||||||||
| Cumbria | ||||||||||
| CA11 7TP | ||||||||||
| The Trustees | ||||||||||
| J Whitehead Citizens Advice South Lakes (Chair) |
||||||||||
| G P Smith Citizens Advice Copeland | (Treasurer) | |||||||||
| J A Auld Citizens Advice Carlisie & Eden | ||||||||||
| A CSpence Citizens Advice Cartisle & | Eden (Resigned | 1 May | ||||||||
| 2022) | ||||||||||
| T M Telford Citizens Advice Allerdale | (Resigned 31 | October 2022) | ||||||||
| D Shepherd Citizens Advice Carlisle & |
Eden | |||||||||
| M C McKinlay Citizens Advice Barrow | In Fumess | |||||||||
| JWhitehead Citizens Advice South Lakes (Chair) |
||||||||||
| K Evans Citizens Advice South Lakes | ||||||||||
| KA Little Citizens Advice Allerdale | ||||||||||
| W Robinson Citizens Advice Barrow In | Fumess | |||||||||
| S Hewitson Citizens Advice Copeland |
||||||||||
| T F Edwards Citizens Advice Copeland |
(Appointed | 1 July 2022) | ||||||||
| Company | Secretary | WJ Robinson | ||||||||
| Independent | Examiner | Jane Ascroft FCA MA (Cantab) | ||||||||
| Enterprise House |
||||||||||
| Harmire Enterprise Park |
||||||||||
| Bamard Castle | ||||||||||
| County Durham |
||||||||||
| DL12 SXT |
| 2023 | 2022 | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | |||||
| funds | funds | Total funds | Total funds | |||
| Note | R | R | ||||
| Income and endowments | ||||||
| Donations and legacies |
856 | |||||
| Charitable activities |
206,011 | 206,011 | 201,500 | |||
| Investment income |
135 | 135 | 1 | |||
| Total income | 135 | 206,011 | 206,146 | 202,357 | ||
| Expenditure | ||||||
| Expenditure on charitable |
activities | 8,9 | 3,865 | 203,839 | 207,704 | 209,087 |
| Total expenditure | 3,865 | 203,839 | 207,704 | 209,087 | ||
| Net expenditure | (3,730) | 2,172 | (1,558) | (6,730) | ||
| Transfers between funds | 2,172 | (2,172) | ||||
| Net movement in funds |
(1,558) | (1,558) | (6,730) | |||
| Reconciliation offunds |
||||||
| Total funds brought forward | 28,610 | 28,610 | 35,340 | |||
| Total funds carried forward | 27,052 | 27,052 | 28,610 |
| 2023 | 2022 | ||||
|---|---|---|---|---|---|
| R | |||||
| Current Assets | |||||
| Debtors | 17,377 | 47,101 | |||
| Cash at bank and in hand | 27,440 | 9,154 | |||
| 44,817 | 56,255 | ||||
| Creditors: amounts | falling | due within one year | 16 | 17,765 | 27,645 |
| Net Current Assets | 27,052 | 28,610 | |||
| Total Assets Less Current | Llabllltles | 27,052 | 28,610 | ||
| Net Assets | 27,052 | 28,610 | |||
| Funds ofthe Charity | |||||
| Unrestricted funds |
27,052 | 28,610 | |||
| Total charity funds | 17 | 27,052 | 28,610 |
| 5. | had undertak Donations |
en to contribute and Legacies |
an amount not exceeding |
F1 in the even | t ofa winding | up. |
|---|---|---|---|---|---|---|
| Unrestricted | Total Funds | Unrestricted | Total Funds | |||
| Funds | 2023 | Funds | 2022 | |||
| F | ||||||
| Donations | ||||||
| Donations | 856 | 856 | ||||
| 6. | Charitable | Activities | ||||
| Restricted | Total Funds | Restricted | Total Funds | |||
| Funds | 2023 | Funds | 2022 | |||
| F | R | E | ||||
| Macmillan Cancer Support | 206,011 | 206,011 | 201,500 | 201,500 | ||
| 7. | Investment | Income | ||||
| Unrestricted | Total Funds | Unrestricted | Total Funds | |||
| Funds | 2023 | Funds | 2022 | |||
| R | ||||||
| Bank interest | 135 | 135 | 1 | |||
| 8. | Expenditure | on Charitable | Activities by Fund Type | |||
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2023 | ||||
| E | E | |||||
| Macmillan Cancer Support | 203,839 | 203,839 | ||||
| Support costs | 3,865 | 3,865 | ||||
| 3,865 | 203,839 | 207,704 | ||||
| Unrestricted | Restricted | Total Funds | ||||
| Funds | Funds | 2022 | ||||
| Macmillan Cancer Support | 199,289 | 199,289 | ||||
| Support costs | 9,798 | 9,798 | ||||
| 9,798 | 199,289 | 209,087 |
| 9. | Expenditure | on Charitabl | e Activ |
ities by Activity Type | |||
|---|---|---|---|---|---|---|---|
| Activities | |||||||
| undertaken | Total funds | Total fund | |||||
| directly Support costs | 2023 | 2022 | |||||
| F | |||||||
| Macmillan Cancer Support | 203,839 | 203,839 | 199,289 | ||||
| Support costs and governance | 3,865 | 3,865 | 9,798 | ||||
| 203,839 | 3,865 | 207,704 | 209,087 | ||||
| 10. | Independent | Examination | Fees | ||||
| 2023 | 2022 | ||||||
| Fees payable | to the independent | examiner for. | |||||
| Independent | examination | ofthe financial statements | 780 |
totalling R2,172 in relation to a set percentage management f Tangible Fixed Assets |
ee. |
|---|---|
| Equipment | |
| Cost | |
| At 1April 2022 and 31 Nlarch 2023 | 1,364 |
| Depreciation | |
| At 1April 2022 and 31 March 2023 | 1,364 |
| Carrying amount |
|
| At 31March 2023 | |
| At 31 March 2022 |
| 15. | Debtors | |||||
|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||
| f | ||||||
| Macmillan | debtor | 17,377 | 47,101 | |||
| 16. | Creditors: | amounts | falling | due within one year | ||
| 2023 | 2022 | |||||
| E | ||||||
| Accruals and deferred | income | 780 | 720 | |||
| Macmillan | partner payments | owed to local CitA offices | 16,985 | 26,925 | ||
| 17,765 | 27,645 |
| At | At 31 | Ilarch | |||||
|---|---|---|---|---|---|---|---|
| 1 April 2022 | Income | Expenditure | Transfers | 2023 | |||
| General funds | 14,610 | 135 | (3,865) | 2,172 | 13,052 | ||
| Designated | Funds | 14,000 | 14,000 | ||||
| 28,610 | 135 | (3,865) | 2,172 | 27,052 | |||
| At | At 31 | March | |||||
| 1 April 2021 | Income | Expenditure F |
Transfers | 2022 f |
|||
| General funds | 21,340 | 857 | (9,798) | 2,211 | 14,610 | ||
| Designated | Funds | 14,000 | 14,000 | ||||
| 35,340 | 857 | 2,211 | 28,610 |
| Restricted | funds | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| At | At | 31 | March | |||||||
| 1 | April | 2022 | Income | Expenditure | Transfers | 2023 | ||||
| MacMillan | Cancer | |||||||||
| Support | 206,011 | (203,839) | (2,172) | |||||||
| At | At | 31 | March | |||||||
| 1 | April | 2021 | Income | Expenditure | Transfers | 2022 | ||||
| MacMillan | Cancer | |||||||||
| Support | 201,500 | (199,289) | (2,211) |
| Analysis of Net Assets Between Funds | ||
|---|---|---|
| Unrestricted | Total Funds | |
| Funds | 2023 | |
| Current assets | 44,817 | 44,817 |
| Creditors less than 1 year | (17,765) | (17,765) |
| Net assets | 27,052 | 27,052 |
| Unrestricted | Total Funds | |
| Funds | 2022 | |
| Current assets | 56,255 | 56,255 |
| Creditors less than 1 year | (27,645) | (27,645) |
| Net assets | 28,610 | 28,610 |
| 2023 | 2022 | ||||
|---|---|---|---|---|---|
| Income and endowments | |||||
| Donations and legacies |
|||||
| Donations | |||||
| Charitable activities |
|||||
| Macmillan Cancer |
Support | 206,011 | 201,500 | ||
| Investment income |
|||||
| Bank interest | 135 | ||||
| Total income | 206,146 | 202,357 | |||
| Expenditure | |||||
| ActNi5es undertaken | directly | ||||
| Partner payments | to local | CitA offices - Macmillan | 203,839 | 199,289 | |
| Support costs | |||||
| Insurance | 177 | 176 | |||
| Independent Examination |
fees | 816 | 720 | ||
| Training costs | 2,700 | 7,900 | |||
| Donation made to |
Local Citizens Advice | 856 | |||
| Other costs | 172 | 146 | |||
| 3,865 | 9,798 | ||||
| Total expenditure | 207,704 | 209,087 | |||
| Net expenditure | (1,556) | (6,730) |